Atlas Trials

Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer

Clinical trial NCT01730833 · COMPLETED

Trial details

NCT number
NCT01730833
Sponsor
City of Hope Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HER2-positive Breast CancerRecurrent Breast CancerStage IIA Breast CancerStage IIB Breast CancerStage IIIA Breast CancerStage IIIB Breast CancerStage IIIC Breast CancerStage IV Breast CancerBreast AdenocarcinomaInflammatory Breast Carcinoma
Start date
2013-07-17
Primary completion
2021-01-12
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.